Skip to main content
Premium Trial:

Request an Annual Quote

Protagen, MicroDiscovery Collaborate on Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German protein research firm Protagen this week said it and MicroDiscovery are collaborating to identify and validate biomarkers.

Protagen will use its UNIArray technology platform while MicroDiscovery will incorporate its software for the analysis of complex biomarker panels as part of the collaboration.

Terms of the deal were not disclosed.

Based in Dortmund, Protagen last month announced it had raised €10 million ($14 million) in a second financing round. In a statement this week, Peter Schulz-Knappe, CSO and executive vice president of diagnostics for Protagen said the deal with Berlin-based MicroDiscovery "strengthens our position in biomarker development and supports the efficient development of marketable products."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.